IHT Wealth Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $563K | Sell |
16,688
-4,064
| -20% | -$137K | 0.02% | 659 |
|
2025
Q1 | $660K | Sell |
20,752
-1,325
| -6% | -$42.1K | 0.02% | 585 |
|
2024
Q4 | $857K | Buy |
22,077
+5,769
| +35% | +$224K | 0.03% | 505 |
|
2024
Q3 | $734K | Buy |
16,308
+5,118
| +46% | +$230K | 0.02% | 593 |
|
2024
Q2 | $467K | Sell |
11,190
-13,750
| -55% | -$574K | 0.02% | 658 |
|
2024
Q1 | $1.14M | Buy |
24,940
+2,238
| +10% | +$102K | 0.05% | 381 |
|
2023
Q4 | $1.05M | Sell |
22,702
-985
| -4% | -$45.5K | 0.05% | 374 |
|
2023
Q3 | $964K | Buy |
23,687
+610
| +3% | +$24.8K | 0.05% | 357 |
|
2023
Q2 | $1.12M | Buy |
23,077
+2,685
| +13% | +$130K | 0.06% | 314 |
|
2023
Q1 | $1M | Buy |
20,392
+5,859
| +40% | +$289K | 0.06% | 309 |
|
2022
Q4 | $735K | Buy |
14,533
+4,534
| +45% | +$229K | 0.05% | 373 |
|
2022
Q3 | $502K | Buy |
9,999
+1,030
| +11% | +$51.7K | 0.04% | 454 |
|
2022
Q2 | $438K | Buy |
8,969
+6,437
| +254% | +$314K | 0.04% | 419 |
|
2022
Q1 | $152K | Buy |
+2,532
| New | +$152K | 0.01% | 729 |
|